Distribution · GCC · Announced 3 Nov 2026
Korea Pharmbio → Ashro Drug Store
Korea Pharmbio signed an export agreement with UAE-based Ashro Drug Store for Eurorex tablets, used to prevent recurrent urinary tract infections, marking the Korean company's first entry into the Middle East.
Parties: Korea Pharmbio (South Korea) → Ashro Drug Store (United Arab Emirates)
- Deal type
- Distribution
- Value
- Undisclosed
- Territory
- United Arab Emirates
- Therapeutic area
- Infectious Disease
- Asset
- Eurorex
- Announced
- 3 Nov 2026
Our analysis
Why this matters
Korea Pharmbio has signed an export agreement with Ashro Drug Store of the United Arab Emirates for Eurorex tablets, a product for preventing recurrent urinary tract infections. The deal was signed on 21 October at the Global Bio & Pharma Plaza 2026 trade fair in Goyang, South Korea, and announced on 3 November. Financial terms, contract length and launch timing were not disclosed.
This is Korea Pharmbio's first agreement in the UAE and its first entry into the Middle East. The company has previously exported to about 10 countries, including the Philippines, Myanmar, Russia, Mongolia, Peru and Nigeria.
The full analysis is free to read with a work email on this page.
Source: Medipana News